Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2014, Article ID 141864, 6 pages
http://dx.doi.org/10.1155/2014/141864
Research Article

Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer

1Department of Pathology, Deen Dayal Upadhyay Hospital, Hari Nagar, New Delhi 110066, India
2Department of Pathology, Saraswathi Institute of Medical Sciences, Anwarpur, Hapur, Uttar Pradesh 245304, India

Received 12 May 2014; Revised 30 September 2014; Accepted 12 October 2014; Published 23 October 2014

Academic Editor: Luigi M. Terracciano

Copyright © 2014 Neelam Sood and Jitendra Singh Nigam. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Kutomi, T. Ohmura, Y. Suzuki1 et al., “Clinicopathological characteristics of basal type breast cancer in triple-negative breast cancer,” Journal of Cancer Therapy, vol. 3, pp. 836–840, 2012. View at Google Scholar
  2. R. Rouzier, C. M. Perou, W. F. Symmans et al., “Breast cancer molecular subtypes respond differently to preoperative chemotherapy,” Clinical Cancer Research, vol. 11, no. 16, pp. 5678–5685, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Bertucci, P. Finetti, N. Cervera et al., “How basal are triple-negative breast cancers?” International Journal of Cancer, vol. 123, no. 1, pp. 236–240, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Rakha and J. S. Reis-Filho, “Basal-like breast carcinoma: from expression profiling to routine practice,” Archives of Pathology & Laboratory Medicine, vol. 133, no. 6, pp. 860–867, 2009. View at Google Scholar · View at Scopus
  5. C. Rao, J. Shetty, and H. L. Kishan Prasad, “Immunohistochemical profile and morphology in triple—negative breast cancers,” Journal of Clinical and Diagnostic Research, vol. 7, no. 7, pp. 1361–1365, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. L. M. Sutton, J. S. Han, K. H. Molberg et al., “Intratumoral expression level of epidermal growth factor receptor and cytokeratin 5/6 is significantly associated with nodal and distant metastases in patients with basal-like triple-negative breast carcinoma,” American Journal of Clinical Pathology, vol. 134, no. 5, pp. 782–787, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Aysola, A. Desai, C. Welch et al., “Triple negative breast cancer—an overview,” Hereditary Genetics, vol. S2, p. 001, 2013. View at Google Scholar
  8. K. Munjal, A. Ambaye, M. F. Evans, J. Mitchell, S. Nandedkar, and K. Cooper, “Immunohistochemical analysis of ER, PR, Her2 and CK5/6 in infiltrative breast carcinomas in indian patients,” Asian Pacific Journal of Cancer Prevention, vol. 10, no. 5, pp. 773–778, 2009. View at Google Scholar · View at Scopus
  9. T. O. Nielsen, F. D. Hsu, K. Jensen et al., “Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma,” Clinical Cancer Research, vol. 10, no. 16, pp. 5367–5374, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. G. H. Tan, N. A. Taib, W. Y. Choo, S. H. Teo, and C. H. Yip, “Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country,” Asian Pacific Journal of Cancer Prevention, vol. 10, no. 3, pp. 395–398, 2009. View at Google Scholar · View at Scopus
  11. A. A. Thike, J. Iqbal, P. Y. Cheok et al., “Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers,” American Journal of Surgical Pathology, vol. 34, no. 7, pp. 956–964, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. D. Foulkes, I. E. Smith, and J. S. Reis-Filho, “Triple-negative breast cancer,” The New England Journal of Medicine, vol. 363, no. 20, pp. 1938–1948, 2010. View at Publisher · View at Google Scholar · View at Scopus